Gene Activity List

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

eRecord

Gene Compound Experiment Study Pathway Assay Report Bug Request Feature

Gene Activity List

You are on Page 121 of 1714:

111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131

Gene	Compound	Assay	Inh	Ic50	Ki	View

progesterone receptor	PHENOTHIAZINE	Progesterone	37%	NoneNone	NoneNone	View
ATPase, Na+/K+ transporting, alpha 1 polypeptide	CELECOXIB	ATPase, Na+/K+	37%	NoneNone	NoneNone	View
ATPase, Na+/K+ transporting, beta 1 polypeptide	CELECOXIB	ATPase, Na+/K+	37%	NoneNone	NoneNone	View
ATPase, Na+/K+ transporting, beta 3 polypeptide	CELECOXIB	ATPase, Na+/K+	37%	NoneNone	NoneNone	View
ATPase, Na+/K+ transporting, beta 2 polypeptide	CELECOXIB	ATPase, Na+/K+	37%	NoneNone	NoneNone	View
ATPase, (Na+)/K+ transporting, beta 4 polypeptide	CELECOXIB	ATPase, Na+/K+	37%	NoneNone	NoneNone	View
ATPase, Na+/K+ transporting, alpha 4 polypeptide	CELECOXIB	ATPase, Na+/K+	37%	NoneNone	NoneNone	View
insulin receptor	OXCARBAZEPINE	Insulin	37%	NoneNone	NoneNone	View
cannabinoid receptor 1 (brain)	LISURIDE	Cannabinoid CB1	37%	NoneNone	NoneNone	View
dopamine receptor D4	QUETIAPINE	Dopamine D4.2	37%	NoneNone	NoneNone	View
adrenergic receptor, beta 2	NITRENDIPINE	Adrenergic beta2	37%	NoneNone	NoneNone	View
adrenergic receptor, alpha 2a	VX-745	Imidazoline I2, Central	37%	NoneNone	NoneNone	View
adrenergic receptor, alpha 2c (Non-specific probe)	VX-745	Imidazoline I2, Central	37%	NoneNone	NoneNone	View
dopamine receptor 2	TERCONAZOLE	Dopamine D2L	37%	NoneNone	NoneNone	View
5-hydroxytryptamine (serotonin) receptor 5B	VX-745	Serotonin 5-HT4	37%	NoneNone	NoneNone	View
5-hydroxytryptamine (serotonin) receptor 4	VX-745	Serotonin 5-HT4	37%	NoneNone	NoneNone	View
Sigma-2 Receptor	PAROXETINE	Sigma2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type I, alpha	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type IX, alpha	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type VII, alpha	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
amiloride-sensitive cation channel 5, intestinal	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type III, beta	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type VIII, alpha polypeptide	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type XI, alpha	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type I, beta	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type 10, alpha polypeptide	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type IV, alpha polypeptide	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type V, alpha polypeptide	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type II, beta	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, nonvoltage-gated 1 alpha	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, nonvoltage-gated 1 gamma	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, nonvoltage-gated 1 beta	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type XI, alpha	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, nonvoltage-gated 1, gamma	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, nonvoltage-gated 1, delta	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome)	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, nonvoltage-gated 1 alpha	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type X, alpha	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type IX, alpha	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage gated, type VIII, alpha	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type VII, alpha	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3)	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type IV, beta	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type IV, alpha	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type III, alpha	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type II, beta	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type II, alpha 2	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type I, beta	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type I, alpha	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type IV, beta	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
5-hydroxytryptamine (serotonin) receptor 2A	U-78517F	Serotonin 5-HT2A	36%	NoneNone	NoneNone	View
acetylcholinesterase (YT blood group)	TANNIC ACID	Acetylcholinesterase	36%	NoneNone	NoneNone	View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase	TANNIC ACID	Acetylcholinesterase	36%	NoneNone	NoneNone	View
acetylcholinesterase	TANNIC ACID	Acetylcholinesterase	36%	NoneNone	NoneNone	View
adrenergic receptor, alpha 2b	DIMENHYDRINATE	Adrenergic alpha2C	36%	NoneNone	NoneNone	View
adrenergic receptor, alpha 2c (Non-specific probe)	DIMENHYDRINATE	Adrenergic alpha2C	36%	NoneNone	NoneNone	View
melanocortin 5 receptor	U-78517F	Melanocortin MC5	36%	NoneNone	NoneNone	View
cannabinoid receptor 1 (brain)	CLOTRIMAZOLE	Cannabinoid CB1	36%	NoneNone	NoneNone	View
histamine receptor H 2	U-78517F	Histamine H2	36%	NoneNone	NoneNone	View
interleukin 8 receptor, beta	AMIODARONE	Chemokine CXCR2 (IL-8B)	36%	NoneNone	NoneNone	View
adrenergic receptor, beta 3	TRETINOIN	Adrenergic beta3	36%	NoneNone	NoneNone	View
adrenergic receptor, alpha 2a	(R)-BICALUTAMIDE	Adrenergic alpha2A	36%	NoneNone	NoneNone	View
leukotriene C4 synthase	ANTIPYRINE	Leukotriene C4 Synthetase	36%	NoneNone	NoneNone	View
leukotriene C4 synthase	ANTIPYRINE	Leukotriene C4 Synthetase	36%	NoneNone	NoneNone	View
melanocortin 5 receptor	BETAHISTINE	Melanocortin MC5	36%	NoneNone	NoneNone	View
adrenergic receptor, alpha 1b	TEMAFLOXACIN	Adrenergic alpha1B	36%	NoneNone	NoneNone	View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	CLOFIBRATE	Dopamine Transporter	36%	NoneNone	NoneNone	View
leukotriene C4 synthase	BISACODYL	Leukotriene C4 Synthetase	36%	NoneNone	NoneNone	View
leukotriene C4 synthase	BISACODYL	Leukotriene C4 Synthetase	36%	NoneNone	NoneNone	View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3	CISAPRIDE	Adenosine Transporter	36%	NoneNone	NoneNone	View
concentrative Na+ nucleoside cotransporter (DBSS)	CISAPRIDE	Adenosine Transporter	36%	NoneNone	NoneNone	View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1	CISAPRIDE	Adenosine Transporter	36%	NoneNone	NoneNone	View
adenine nucleotide translocase (DBSS) (Non-specific probe)	CISAPRIDE	Adenosine Transporter	36%	NoneNone	NoneNone	View
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4	CISAPRIDE	Adenosine Transporter	36%	NoneNone	NoneNone	View
cholinergic receptor, muscarinic 4	TETRACAINE	Muscarinic M4	36%	NoneNone	NoneNone	View
melanocortin 5 receptor	CLEMASTINE	Melanocortin MC5	36%	NoneNone	NoneNone	View
angiotensin 1 converting enzyme 1	BENAZEPRIL	Protease, Angiotensin Converting Enzyme	36%	NoneNone	NoneNone	View
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1	BENAZEPRIL	Protease, Angiotensin Converting Enzyme	36%	NoneNone	NoneNone	View
adenine nucleotide translocase (DBSS) (Non-specific probe)	ESTRONE	Adenosine Transporter	36%	NoneNone	NoneNone	View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2	ESTRONE	Adrenergic, Norepinephrine Transporter	36%	NoneNone	NoneNone	View
5-hydroxytryptamine (serotonin) receptor 2B	ETHINYLESTRADIOL	Serotonin 5-HT2B	36%	NoneNone	NoneNone	View
phosphodiesterase 5A, cGMP-specific	NOCODAZOLE	Phosphodiesterase PDE5	36%	NoneNone	NoneNone	View
phosphodiesterase 5A, cGMP-specific	NOCODAZOLE	Phosphodiesterase PDE5	36%	NoneNone	NoneNone	View
thromboxane A synthase 1	KETOROLAC	Thromboxane Synthetase	36%	NoneNone	NoneNone	View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A)	KETOROLAC	Thromboxane Synthetase	36%	NoneNone	NoneNone	View
dopamine receptor D4	MESTRANOL	Dopamine D4.2	36%	NoneNone	NoneNone	View
A3 adenosine receptor	BIS(2-ETHYLHEXYL)PHTHALATE	Adenosine A3	36%	NoneNone	NoneNone	View
arachidonate 15-lipoxygenase, second type	CAPTOPRIL	Lipoxygenase 15-LO	36%	NoneNone	NoneNone	View
arachidonate 15-lipoxygenase	CAPTOPRIL	Lipoxygenase 15-LO	36%	NoneNone	NoneNone	View
arachidonate 15-lipoxygenase	CAPTOPRIL	Lipoxygenase 15-LO	36%	NoneNone	NoneNone	View
progesterone receptor	BISPHENOL A	Progesterone	36%	NoneNone	NoneNone	View
progesterone receptor	BISPHENOL A	Progesterone	36%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type IV, beta	BISPHENOL A	Sodium Channel, Site 2	36%	NoneNone	NoneNone	View
sodium channel associated protein 1	BISPHENOL A	Sodium Channel, Site 2	36%	NoneNone	NoneNone	View
sodium channel associated protein 2	BISPHENOL A	Sodium Channel, Site 2	36%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type III, beta	BISPHENOL A	Sodium Channel, Site 2	36%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type I, alpha	BISPHENOL A	Sodium Channel, Site 2	36%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type IX, alpha	BISPHENOL A	Sodium Channel, Site 2	36%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type VII, alpha	BISPHENOL A	Sodium Channel, Site 2	36%	NoneNone	NoneNone	View
amiloride-sensitive cation channel 5, intestinal	BISPHENOL A	Sodium Channel, Site 2	36%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type III, beta	BISPHENOL A	Sodium Channel, Site 2	36%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type VIII, alpha polypeptide	BISPHENOL A	Sodium Channel, Site 2	36%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type XI, alpha	BISPHENOL A	Sodium Channel, Site 2	36%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type I, beta	BISPHENOL A	Sodium Channel, Site 2	36%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type 10, alpha polypeptide	BISPHENOL A	Sodium Channel, Site 2	36%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type IV, alpha polypeptide	BISPHENOL A	Sodium Channel, Site 2	36%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type V, alpha polypeptide	BISPHENOL A	Sodium Channel, Site 2	36%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type II, beta	BISPHENOL A	Sodium Channel, Site 2	36%	NoneNone	NoneNone	View
sodium channel, nonvoltage-gated 1 alpha	BISPHENOL A	Sodium Channel, Site 2	36%	NoneNone	NoneNone	View
sodium channel, nonvoltage-gated 1 gamma	BISPHENOL A	Sodium Channel, Site 2	36%	NoneNone	NoneNone	View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1	IMATINIB	GABAA, Benzodiazepine, Central	38%	NoneNone	NoneNone	View
gamma-aminobutyric acid A receptor, delta	IMATINIB	GABAA, Benzodiazepine, Central	38%	NoneNone	NoneNone	View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3	IMATINIB	GABAA, Benzodiazepine, Central	38%	NoneNone	NoneNone	View
Cytochrom P450-2D6 monooxygenase	ALOSETRON	CYP450-2D6 Inhibition	38%	NoneNone	NoneNone	View
Cytochrom P450-2D6 monooxygenase	RIFAPENTINE	CYP450-2D6 Inhibition	38%	NoneNone	NoneNone	View
Cytochrom P450-2D6 monooxygenase	QUETIAPINE	CYP450-2D6 Inhibition	38%	NoneNone	NoneNone	View
Cytochrom P450-2D6 monooxygenase	LIDOCAINE	CYP450-2D6 Inhibition	38%	NoneNone	NoneNone	View
Cytochrom P450-2D6 monooxygenase	DICYCLOMINE	CYP450-2D6 Inhibition	38%	NoneNone	NoneNone	View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase)	MONOBENZONE	CYP450-2C9 Inhibition	38%	NoneNone	NoneNone	View
cytochrome P450, family 2, subfamily C, polypeptide 9	MONOBENZONE	CYP450-2C9 Inhibition	38%	NoneNone	NoneNone	View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase)	(R)-BICALUTAMIDE	CYP450-2C9 Inhibition	38%	NoneNone	NoneNone	View
cytochrome P450, family 2, subfamily C, polypeptide 9	(R)-BICALUTAMIDE	CYP450-2C9 Inhibition	38%	NoneNone	NoneNone	View
5-hydroxytryptamine (serotonin) receptor 2A	BUFLOMEDIL	Serotonin 5-HT2A	38%	NoneNone	NoneNone	View
Sigma-2 Receptor	3,3',4',5-TETRACHLOROSALICYLANILIDE	Sigma2	38%	NoneNone	NoneNone	View
insulin receptor	DIPHENIDOL	Insulin	38%	NoneNone	NoneNone	View
insulin receptor	DIPHENIDOL	Insulin	38%	NoneNone	NoneNone	View
lymphocyte protein tyrosine kinase (mapped)	3,3',4',5-TETRACHLOROSALICYLANILIDE	Protein Tyrosine Kinase, Lck	38%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 8	VINBLASTINE	Calcium Channel Type L, Dihydropyridine	38%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 7	VINBLASTINE	Calcium Channel Type L, Dihydropyridine	38%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 6	VINBLASTINE	Calcium Channel Type L, Dihydropyridine	38%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 5	VINBLASTINE	Calcium Channel Type L, Dihydropyridine	38%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 4	VINBLASTINE	Calcium Channel Type L, Dihydropyridine	38%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 3	VINBLASTINE	Calcium Channel Type L, Dihydropyridine	38%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 2	VINBLASTINE	Calcium Channel Type L, Dihydropyridine	38%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 1	VINBLASTINE	Calcium Channel Type L, Dihydropyridine	38%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 4 subunit	VINBLASTINE	Calcium Channel Type L, Dihydropyridine	38%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 3 subunit	VINBLASTINE	Calcium Channel Type L, Dihydropyridine	38%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 2 subunit	VINBLASTINE	Calcium Channel Type L, Dihydropyridine	38%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1S subunit	VINBLASTINE	Calcium Channel Type L, Dihydropyridine	38%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, alpha 1F subunit	VINBLASTINE	Calcium Channel Type L, Dihydropyridine	38%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1D subunit	VINBLASTINE	Calcium Channel Type L, Dihydropyridine	38%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1C subunit	VINBLASTINE	Calcium Channel Type L, Dihydropyridine	38%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	VINBLASTINE	Calcium Channel Type L, Dihydropyridine	38%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 1 subunit	VINBLASTINE	Calcium Channel Type L, Dihydropyridine	38%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1E subunit	VINBLASTINE	Calcium Channel Type L, Dihydropyridine	38%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, N type, alpha 1B subunit	VINBLASTINE	Calcium Channel Type L, Dihydropyridine	38%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, alpha2/delta subunit 1	VINBLASTINE	Calcium Channel Type L, Dihydropyridine	38%	NoneNone	NoneNone	View
opioid receptor, delta 1	MEDROXYPROGESTERONE ACETATE	Opiate delta	38%	NoneNone	NoneNone	View
opioid receptor, kappa 1	ETHYLESTRENOL	Opiate kappa	38%	NoneNone	NoneNone	View
mitogen activated protein kinase 3	CLOSANTEL	Protein Serine/Threonine Kinase, ERK1	38%	NoneNone	NoneNone	View
mitogen-activated protein kinase 3	CLOSANTEL	Protein Serine/Threonine Kinase, ERK1	38%	NoneNone	NoneNone	View
opioid receptor, delta 1	CLOSANTEL	Opiate delta	38%	NoneNone	NoneNone	View
tachykinin receptor 2	DACTINOMYCIN	Tachykinin NK2	38%	NoneNone	NoneNone	View
prostaglandin-endoperoxide synthase 1	DIGITONIN	Cyclooxygenase COX-1	38%	NoneNone	NoneNone	View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)	DIGITONIN	Cyclooxygenase COX-1	38%	NoneNone	NoneNone	View
opioid receptor, delta 1	BENZTROPINE	Opiate delta	38%	NoneNone	NoneNone	View
histamine receptor H 2	PYRILAMINE	Histamine H2	38%	NoneNone	NoneNone	View
phosphodiesterase 4A, cAMP specific	DIHYDROERGOCRISTINE MESYLATE	Phosphodiesterase PDE4	38%	NoneNone	NoneNone	View
phosphodiesterase 4C, cAMP-specific	DIHYDROERGOCRISTINE MESYLATE	Phosphodiesterase PDE4	38%	NoneNone	NoneNone	View
phosphodiesterase 4D	DIHYDROERGOCRISTINE MESYLATE	Phosphodiesterase PDE4	38%	NoneNone	NoneNone	View
phosphodiesterase 4B, cAMP specific	DIHYDROERGOCRISTINE MESYLATE	Phosphodiesterase PDE4	38%	NoneNone	NoneNone	View
tachykinin receptor 1	TERCONAZOLE	Tachykinin NK1	38%	NoneNone	NoneNone	View
prostaglandin-endoperoxide synthase 2	SUMATRIPTAN	Cyclooxygenase COX-2	38%	NoneNone	NoneNone	View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)	SUMATRIPTAN	Cyclooxygenase COX-2	38%	NoneNone	NoneNone	View
cytochrome P450, family 3, subfamily a, polypeptide 13	BISACODYL	CYP450-3A4 Inhibition	38%	NoneNone	NoneNone	View
histamine receptor H 1	HEXACHLOROPHENE	Histamine H1, Central	38%	NoneNone	NoneNone	View
sodium channel associated protein 1	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel associated protein 2	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type III, beta	IDARUBICIN	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
cathepsin G	IDARUBICIN	Protease, Cathepsin G	37%	NoneNone	NoneNone	View
mast cell protease 9	IDARUBICIN	Protease, Cathepsin G	37%	NoneNone	NoneNone	View
caspase 1	DAUNORUBICIN	Protease, Caspase 1	37%	NoneNone	NoneNone	View
caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase)	DAUNORUBICIN	Protease, Caspase 1	37%	NoneNone	NoneNone	View
caspase 3, apoptosis related cysteine protease	DAUNORUBICIN	Protease, Caspase 1	37%	NoneNone	NoneNone	View
caspase 2	DAUNORUBICIN	Protease, Caspase 1	37%	NoneNone	NoneNone	View
caspase 7	DAUNORUBICIN	Protease, Caspase 1	37%	NoneNone	NoneNone	View
caspase 6	DAUNORUBICIN	Protease, Caspase 1	37%	NoneNone	NoneNone	View
cytochrome P450, family 3, subfamily a, polypeptide 13	PIOGLITAZONE	CYP450-3A4 Inhibition	37%	NoneNone	NoneNone	View
prostaglandin-endoperoxide synthase 1	GW-1929	Cyclooxygenase COX-1	37%	NoneNone	NoneNone	View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)	GW-1929	Cyclooxygenase COX-1	37%	NoneNone	NoneNone	View
5-hydroxytryptamine (serotonin) receptor 5B	GW-1929	Serotonin 5-HT4	37%	NoneNone	NoneNone	View
5-hydroxytryptamine (serotonin) receptor 4	GW-1929	Serotonin 5-HT4	37%	NoneNone	NoneNone	View
cholinergic receptor, muscarinic 2	PIPAMAZINE	Muscarinic M2	37%	NoneNone	NoneNone	View
adrenergic receptor, alpha 1b	ECONAZOLE	Adrenergic alpha1B	37%	NoneNone	NoneNone	View
Cytochrom P450-2A6 monooxygenase	MICONAZOLE	CYP450-2A6 Inhibition	37%	NoneNone	NoneNone	View
cholinergic receptor, muscarinic 5	VECURONIUM BROMIDE	Muscarinic M5	37%	NoneNone	NoneNone	View
sodium channel, nonvoltage-gated 1 gamma	LEVOBUNOLOL	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, nonvoltage-gated 1 beta	LEVOBUNOLOL	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide	LEVOBUNOLOL	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type XI, alpha	LEVOBUNOLOL	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, nonvoltage-gated 1, gamma	LEVOBUNOLOL	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, nonvoltage-gated 1, delta	LEVOBUNOLOL	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome)	LEVOBUNOLOL	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, nonvoltage-gated 1 alpha	LEVOBUNOLOL	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type X, alpha	LEVOBUNOLOL	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type IX, alpha	LEVOBUNOLOL	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage gated, type VIII, alpha	LEVOBUNOLOL	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type VII, alpha	LEVOBUNOLOL	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3)	LEVOBUNOLOL	Sodium Channel, Site 2	37%	NoneNone	NoneNone	View